Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
HEALTH ODYSSEY - PRENATAL NUTRITION
Impact of Maternal Nutrition on Fetal Development
December 2010
Nutrition is perhaps the most influential non-genetic factor in fetal development.1 Maternal body composition, nutritional stores, diet, and ability to deliver nutrients through the placenta determines nutrient availability for...
PRIORITY PRESS - 2010 Advances in Inflammatory Bowel Diseases
Escalate or Switch? Managing Loss of Response in Inflammatory Bowel Disease
Hollywood, Florida / December 9-12, 2010
Hollywood - Treatment of Crohn’s disease (CD) and ulcerative colitis (UC) is highly individualized, focusing on the amelioration of acute and chronic symptoms and maintenance of remission. Patient responses are also highly individualized,...
PRIORITY PRESS - 2010 Advances in Inflammatory Bowel Diseases
IBD Therapies: Real-world Problems, Practical Solutions
Hollywood, Florida / December 9-12, 2010
Hollywood - Real-world experience with therapies for the inflammatory bowel diseases Crohn’s disease and ulcerative colitis demonstrates that patient responses to currently available treatments or surgical interventions can vary widely....
PRIORITY PRESS - 33rd Annual San Antonio Breast Cancer Symposium
The Role of Bisphosphonates in Adjuvant Therapy for Breast Cancer
San Antonio, Texas / December 9-12, 2010
Bisphosphonates (BPs) have a well-established therapeutic role in prevention of skeletal events in cancer patients by impairing malignant osteolysis to interrupt bone destruction and cancer growth. Preclinical studies have suggested that...
PRIORITY PRESS - 33rd Annual San Antonio Breast Cancer Symposium
Aromatase Inhibitors as Upfront Endocrine Therapy in Early Breast Cancer
San Antonio, Texas / December 9-12, 2010
Aromatase inhibitors (AIs) have an established role in adjuvant endocrine therapy for early breast cancer. However, according to Dr. Paul Goss, Massachusetts General Hospital, Harvard Medical School, Boston, structural and molecular...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Invasive Pneumococcal Disease in Older Adults
Quebec City, Quebec / December 5-8, 2010
Quebec City - Pneumococcal disease has a bimodal pattern of presentation, affecting the very young and the very old. In 2002, depending on the province, the 7-valent pneumococcal conjugate vaccine was incorporated into publicly funded...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Adjuvanted Vaccines and the Immune System: Improving Response of Influenza Vaccines in the Elderly
Quebec City, Quebec / December 5-8, 2010
Quebec City - Adjuvants are often added to a vaccine in order to activate immune responses robust enough to protect against infection. In the elderly, the cytotoxic T-cell response to immunization is typically blunted, resulting in...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
HPV Vaccination for Males—Disease Burden Equivalent to Females
Quebec City, Quebec / December 5-8, 2010
Quebec City - Currently, vaccination against the human papillomavirus (HPV) is offered to females between 9 and 26 years of age, but uptake of the vaccine varies from province to province and many young women remain unvaccinated. Many now...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Publicly-funded Childhood Immunization Programs: Update on the 13-valent Pneumococcal Vaccine
Quebec City, Quebec / December 5-8, 2010
Quebec City - The 7-valent pneumococcal conjugate vaccine (PCV7) has been part of the publicly-funded childhood immunization program for a number of years. With its high efficacy and uptake rates, the incidence of invasive pneumococcal...